April 9, 2018 | Posted by Team in News |
PALO ALTO, Calif., April 9, 2018–Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development services, announced a collaboration with Ranomics to offer online access to its mutagenesis platform to scientists around the globe.
Ranomics is a Toronto-based biotechnology company whose mission is to enable transformative discoveries using genomics. The VariantFind™ platform offers unique mutagenesis services to build comprehensive variant libraries on complex and long DNA sequences, enabling its partners to make breakthrough discoveries.
“We are proud to team up with Science Exchange, a move that will give life sciences communities all over the world quick and easy access to quality science,” says Leo Wan, Ph.D., CEO and co-founder of Ranomics. “Our core strength has always been building cost-effective and diverse DNA libraries rapidly. Now we can effectively assist customers who want to use these libraries in high-throughput cell-based assays as part of a more full-service approach to pre-clinical research.”
“We are thrilled to partner with Ranomics to make its innovative gene mutagenesis services available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is always looking to add innovative and qualified providers to our platform, giving scientists quick access to a comprehensive selection of research services. Ranomics has impressed us with their superb progress in mutagenesis and cell-based screening.”
About Ranomics
Ranomics is a Toronto-based biotechnology company whose mission is to enable transformative discoveries using genomics. Ranomics’s proprietary functional genomics platform offers unparalleled ability to study genetic variations within the context of fundamental biology and drug discovery. The platform promotes unbiased and systematic characterization of gene variations, leading to the development of novel therapeutics in a derisked and cost-effective manner. The VariantFind™ technology is a key component of Ranomics’s functional genomics platform, and offers unprecedented scalability and flexibility in building DNA variant libraries. The VariantFind™ technology is used by partners to find meaningful variants in their research programs that will propel discovery and make better products. Ranomics is committed to providing top-quality variant libraries at competitive costs with quick turnaround time for all partners. Ranomics is an alumnus of IndieBio and graduate of JLabs Toronto.
Start finding target gene variations today! Request a quote at the Ranomics storefront:
April 3, 2018 | Posted by Team in News |
Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development services, announced a collaboration with Murray Rheology Consulting to offer online access to its rheology training, problem-solving, and technical writing services to scientists and engineers around the globe.
Murray Rheology Consulting is an LLC based in West Lafayette, Indiana, USA, whose mission is to help researchers and industrial scientists who are developing soft materials by providing them with rheological analysis and test method development services.
“Science Exchange is our platform of choice because of its worldwide reach and dedication to helping life science labs connect with specialists,” says Lisa R. Murray, Ph.D., General Manager and Lead Consultant of Murray Rheology Consulting. “Science Exchange helps us stay engaged with our clients, so that we can better design customized test methods for their product development, quality control, and research. Our firm is passionate about helping other companies overcome barriers to fluid and gel scale-up so that their products can reach the market faster.”
“We are thrilled to collaborate with Murray Rheology Consulting to make its rheology consulting services readily available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is dedicated to adding innovative and qualified providers to our platform, giving scientists quick access to a comprehensive selection of research resources. Murray Rheology Consulting met our rigorous qualification criteria while demonstrating in-depth expertise in the field of rheology.
About Murray Rheology Consulting
Murray Rheology Consulting was founded in 2017 with a focus on giving industrial scientists training and advice for improving soft material development. Current projects include online rheology training for technicians, engineers, and scientists along with technical reviews for biomedical rheological test designs. Our PhD rheologist provides custom trainings and onsite consultation. The wide assortment of industries assisted by Murray Rheology Consulting brings creative approaches to our analyses and solutions. From colloids to hydrogels to emulsions, we handle the planning and analyses of physical properties to solve problems. Murray Rheology Consulting can be found on Twitter @MurrayRheology.
Connect with Murray Rheology Consulting today to discuss your product development program’s biorheology testing requirements — click “Request Quote” to describe your project!
March 30, 2018 | Posted by Team in News |
Science Exchange shortlisted in two categories – Best New Procurement Consultancy Project and Best P2P Specialist Provider
PALO ALTO, CA, March 30, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, today announced it has been named a finalist in two categories for the esteemed World Procurement Awards, the most sought-after and recognized accolade in procurement, run by Procurement Leaders. Alongside industry leaders like Microsoft, Coupa, IBM, and KPMG, Science Exchange is on the shortlist for two awards: Best New Procurement Consultancy Project, with pharmaceutical client GlaxoSmithKline (GSK) Consumer Health, and Best Procure-to-Pay (P2P) Specialist Provider.
Science Exchange was recognized for its P2P platform, which empowered procurement teams and increased R&D operational efficiency at GlaxoSmithKline Consumer Health (GSK-CH) and another major global pharmaceutical client with rapid access to innovation through outsourced R&D.
“We are honored to be recognized once again by Procurement Leaders for the work we are doing with our clients to help accelerate breakthrough discoveries,” said Dr. Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange. “Outsourcing with scientific service providers is crucial for increasing R&D efficiency, but finding and qualifying providers can be a time-consuming process. Our platform accelerates scientific breakthroughs by connecting researchers to thousands of scientific services from a network of thoroughly vetted providers.”
The winners of the awards will be announced on May 17, 2018 at the World Procurement Awards Ceremony in London, England. To find out more and see a list of all the finalists, visit the website at www.worldprocurementawards.com.
Best New Procurement Consultancy Project
In the category Best New Procurement Consultancy Project, GlaxoSmithKline Consumer Health (GSK-CH) implemented Science Exchange to increase the productivity of their R&D operations. Through the Science Exchange platform, GSK-CH researchers gained instant access to the 2,500+ outsourced service providers on the Science Exchange network, including niche and innovative technologies. Science Exchange was able to broaden the GSK-CH R&D organization’s geographical reach, capitalize on local demand, help spur innovation, and advance their timelines to bring products to market faster. Some of the results included an 11% increase in GSK-CH’s access to innovative providers (YTD) and 44 new niche providers selected by GSK-CH during scouting efforts this year.
Best P2P Specialist Provider In the category Best P2P Specialist Provider, a leading global pharmaceutical company explored the potential to increase their R&D productivity by using the Science Exchange technology platform to improve its outsourcing processes. Instead of spending hours a day exploring service providers, the scientists logged into Science Exchange and quickly reviewed service provider satisfaction ratings, secured competitive quotes, and selected a supplier to meet their research needs. After one year of using Science Exchange, this global pharmaceutical company’s preclinical services group reported that scientists saved 1,300 hours, the legal and procurement teams saved 2,730 hours, and the combined time-savings translated to hundreds of thousands of dollars in cost savings.
About World Procurement Awards The World Procurement Awards, in association with SAP Ariba, are the most celebrated and sought-after awards in procurement, representing the best projects, people and organizations across the world. They reward the collective efforts of individuals and teams and are an affirmation of the hard work, innovation and dedication of those at the forefront of this dynamic global profession. This year saw a record number of entries from some of the most influential companies across 36 countries for the 12th annual awards. The judges were impressed with the sheer quality of this year’s submissions, commenting that the bar had once again been raised, with innovation at the heart of each project as teams across the globe work hard to position themselves as valuable business partners.
Learn more about how Science Exchange can help your organization accelerate innovation through outsourced R&D — request a demo of our platform today.
March 19, 2018 | Posted by Team in News |
PALO ALTO, CA, March 6, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development services, announced a collaboration with PhenoSwitch Bioscience to offer online access to its mass spectrometry (LC-MS/MS) services, including SWATH™ proteomics offerings to scientists around the globe.
PhenoSwitch Bioscience is a Quebec, Canada-based contract research organization (CRO) whose mission is to help scientists elevate their research projects with innovative mass spectrometry solutions, in a collaborative manner.
“We are proud to team up with Science Exchange as we share similar philosophies: giving scientists quick and easy access to quality science,” says Hugo Gagnon, Ph.D., CEO and co-founder of PhenoSwitch Bioscience. “Our continuous internal mission to optimize our workflows, attentive listening to our client’s needs and careful scientific revisions are the keys to our success when offering complex services like LC-MS/MS and SWATH™ omics. Moreover, being a small, multidisciplinary scientific team allows us to be flexible and able to accommodate custom requests.”
“We are excited to collaborate with PhenoSwitch Bioscience to make its mass spectrometry services readily available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is heartily committed to adding innovative and qualified providers to our platform, giving scientists quick access to a comprehensive selection of research services. PhenoSwitch Bioscience met our rigorous qualification criteria while demonstrating breakthrough discoveries in the field of drug development, biomarker discovery and fundamental science.”
About PhenoSwitch Bioscience
PhenoSwitch Bioscience Inc. was established in 2013 with the goal of providing expert services in mass spectrometry to major actors in the life science research industry. Today, PhenoSwitch uses the 20+ years of combined life science research experience of its Ph.D. level scientists to help solve research and/or drug discovery problems with modern mass spectrometry approaches. Our team’s commitment and in-depth understanding of mass spectrometry brought us among the world’s leaders in SWATH™ omics technology. We have also grown a unique expertise in the development of high sensitivity micro-flow LC-MS/MS methods. Apart from our proteomics, lipidomics and metabolomics services, we also offer several pre-developed targeted quantitative panels as well as custom methods development for small and large molecules bioanalysis in complex matrices. Follow the company on Twitter @PhenoSwitch.
Interested in learning more about PhenoSwitch Bioscience’s technologies? Request a quote to receive information:
March 12, 2018 | Posted by Team in News |
PALO ALTO, CA, March 12, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with PhenoVista Biosciences to offer online access to its Phenotypic Assay Development Services to scientists around the globe.
“Science Exchange has been a steadfast ally of ours since we founded PhenoVista back in 2014. They have always understood the strength of our quantitative imaging-based approach and immediately recognized the great strides our scientists make to deliver the highest quality data possible. We’re very excited about taking our relationship with Science Exchange to the next level and look forward to working with new groups of scientists across the globe.” says James G. Evans, Ph.D., CEO and Founder of PhenoVista Biosciences. PhenoVista Biosciences is a San Diego, California-based CRO and is the leading provider of custom phenotypic assay services. The company’s mission is to enrich the drug discovery community with high-quality information derived from physiologically relevant cell models. PhenoVista specializes in custom assay development in a wide range of therapeutic areas, including CNS, immuno-oncology, and rare diseases.
“We’re delighted to strengthen our partnership with PhenoVista to ensure that their cutting-edge assay services can be made more easily available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is committed to adding the most innovative and qualified providers to our platform, so scientists have the secure services they need readily available to aid their discoveries. PhenoVista met our rigorous standards for quality and compliance while demonstrating breakthrough discoveries in the field of phenotypic assays.”
About PhenoVista Biosciences
PhenoVista is the leading provider of custom imaging-based phenotypic assay services. With a collaborative and scientifically-driven project design and management approach, PhenoVista has a proven track record of delivering high quality data from robust and scalable assays. A key advantage that PhenoVista leverages is the ability of their industry-trained scientists to combine world-class understanding of diverse biological systems, with cutting-edge quantitative imaging to deliver clear, actionable output data. PhenoVista’s clients include the majority of top-20 pharmaceutical companies as well as numerous VC-funded biotechnology start-ups. PhenoVista was founded by Dr. James G. Evans and Dr. Anthony Essex in 2014. A privately funded and revenue-driven company, PhenoVista continues to see double-digit revenue growth year over year.
Connect with the PhenoVista team by requesting a quote on their storefront today!
March 6, 2018 | Posted by Team in News |
PALO ALTO, CA, March 6, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development services, announced a partnership with CARE Research, LLC to offer online access to its preclinical services to scientists around the globe.
CARE Research, LLC is a Colorado-based contract research organization (CRO) and a foremost provider of preclinical research. The company’s mission is to deliver services that are competitively priced, of superior quality, and rendered with a high degree of responsiveness that ensures ease of FDA approval.
“Our partnership with Science Exchange allows us to widen our operational reach and to find clients we wouldn’t have connected with had we only used our internal resources,” said Rajan Bawa, Ph.D., co-founder and CEO of CARE Research, LLC. “Additionally, the project managers with whom we have interacted are very responsive, helpful and easily available to answer any questions and facilitate sponsor interactions.”
“We are excited to partner with CARE Research, LLC to make its preclinical in vivo services readily available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is steadfastly committed to adding new innovative and qualified providers to our platform, so scientists have quick access to a breadth of research services. CARE Research, LLC met our rigorous standards for quality and compliance while demonstrating breakthrough discoveries in the field of in vivo research.”
About CARE Research, LLC
CARE Research, LLC is a leader in customized preclinical studies with quick turnaround, competitive costing and humane animal handling procedures under strict regulatory compliance. Our experienced, hands-on scientists design and conduct studies that facilitate regulatory approval. Our studies enable both large and small life science companies to achieve their design and exploration goals as well as obtain marketing approval. Our services include a wide range: PK/ MTD, DART, toxicology, IND/NDA enabling studies for drugs and biomedical devices. Our clinical pathology and histopathology capabilities afford a single point of control to our study sponsors. We offer a variety of animal models including rodents, rabbits, dogs, guinea pigs, pigs, mini pigs, goats, sheep, cattle, and horses.
Need animal studies? Submit your preclinical study scope of work to receive a quote from the CARE Research team:
February 28, 2018 | Posted by Team in News |
PALO ALTO, CA, February 28, 2018 – Science Exchange, the world’s leading platform for outsourced research and development (R&D) services, announced a partnership with Likarda to offer online access to its innovative 3D compound screening and assay development services to scientists around the globe.
Likarda is a Kansas City-based contract research organization (CRO) and a leading provider of drug discovery and development services, primarily using 3D cell-based assaying technologies and microencapsulation. The company’s mission is to combine comprehensive early-phase discovery research with consultative and analytical services so that those in the drug discovery process can move forward confidently, efficiently, and affordably.
“We focus on bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. To illustrate, our proprietary three-dimensional cell culture system serves as a predictive model to demonstrate how test drug compounds work in the human body. Partnering with Science Exchange gives its global client base the fastest path to our novel technologies and services,” stated Karthik Ramachandran, Ph.D., Likarda’s vice president and co-founder.
“We are excited to team up with Likarda to make its drug screening and assay development services accessible to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is committed to adding the most innovative and qualified service providers to our platform, so scientists can securely and readily access the services they need to aid their discoveries. Likarda met our rigorous standards for quality and compliance while demonstrating breakthrough discoveries in the field of 3D cell-based assaying technologies and microencapsulation.”
About Likarda
Founded in 2012, Likarda LLC is a world-class, cutting-edge biotech research laboratory for science entrepreneurs, pharmaceutical and nutraceutical companies, animal health, and contract research organizations (CRO). We focus on bringing to market disruptive technologies that improve health-care outcomes and lower costs for pets and people alike. Follow the CRO on Twitter @likardallc.
Interested in trying out Likarda’s technologies for your project?
Request a quote from the Likarda team
February 12, 2018 | Posted by Team in News |
Palo Alto, CA – February 12, 2018 — Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D), today announced a strategic collaboration with Venture Catalyst, a unit within the Technology Management and Corporate Relations division of the UC Davis Office of Research which supports the development of new ventures fueled by university research.
Science Exchange will provide entrepreneurs and startups participating in the Venture Catalyst Smart Toolkit for Accelerated Research Translation (START™) Program immediate access to the private R&D marketplace with dedicated PhD-level sourcing support around the clock and a special contracting structure to accelerate their research and development projects.
“The Science Exchange platform solves the challenges of R&D outsourcing by providing scientists with on-demand access to a diverse network of prequalified external providers under a single relationship while also providing sourcing departments with more information and control over their outsourcing spending,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “We are thrilled to be collaborating with Venture Catalyst to offer a customized R&D marketplace and help its portfolio of companies complete their research and clinical projects more quickly and efficiently. It’s clear that Venture Catalyst is supporting companies with extremely promising technologies in development, and we’re honored to help get their discoveries to market faster.”
With this collaboration, Science Exchange will support client-specific governance, approval workflows, and preferred vendors, all the while enabling instant access to research services and custom products from 2,500 providers in over 6,000 research areas. To help external service providers minimize the risk frequently associated with outsourcing, Science Exchange’s guarantee ensures complete protection of data, assets and performance of agreed-upon services, all backed by the best-in-class, SOC 2-compliant information technology security infrastructure. Science Exchange’s ISO 9001-certified quality assurance system and dedicated regulatory compliance team also support regulated outsourced work.
Venture Catalyst is the latest innovation and startup support organization to choose to partner with Science Exchange. They now join more than 30 enterprise organizations including most of the top 20 biopharma companies that use Science Exchange to more efficiently manage outsourced R&D.
“Science Exchange offers a unique platform for our startups to connect with a broad network of qualified scientific providers,” said Dushyant Pathak, Associate Vice Chancellor of Research and Executive Director of Venture Catalyst at UC Davis. “We anticipate that working with Science Exchange through the START Program will enable us to commercially advance the discoveries made by Venture Catalyst-supported startups and early-stage companies, in areas as diverse as biomedical and life sciences, agriculture and animal health, and physical sciences and engineering.”
About Venture Catalyst
Venture Catalyst furthers the University’s educational, research and public mission by supporting UC Davis students, faculty and researchers in translating science, engineering and innovative research through well-resourced startups, into societal impact. Venture Catalyst engages collaboratively with internal and external drivers of innovation and works closely with the University’s Institute for Innovation & Entrepreneurship. In addition to its Smart Toolkit for Accelerated Research Translation (START™) program, Science Translation and Innovative Research (STAIR™) Proof-of-Concept grants, Venture Catalyst supports a network of regional technology startup incubators through its Distributed Research Incubation & Venture Engine (DRIVE™) Network.
February 8, 2018 | Posted by Team in News |
PALO ALTO, CA, February 07, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced the partnership with OnRamp BioInformatics, Inc. (OnRamp.Bio) to offer industry-leading bioinformatics services and tools to scientists around the globe.
Genomics big data and complex software analyses have historically required highly trained PhDs in bioinformatics using complicated command-line tools. OnRamp.Bio’s intuitive user interface, automated analyses and robust data management make it faster and easier for scientists, biologists, clinicians and other medical professionals to obtain interpretations of genomic data without the complexity of traditional deployments.
“IT and software complexity has stood in the way of progress for far too long. We’ve combined our deep knowledge of IT, software development and biology to provide intuitive, integrated systems and services that accelerate the mainstream adoption of NGS analyses within research, biotech and pharma,” said Tim Wesselman, CEO of OnRamp.Bio. “Genomic data is the currency of future medicine; there is nothing mankind has that is more valuable and we are excited to be working with Science Exchange to offer our support to researchers far and wide.”
OnRamp.Bio is a San Diego-based CRO and a leading provider of interactive genomic analysis. The company’s mission is to empower researchers, biologists and scientists with genomic answers and insights that they can understand and put to action. OnRamp.Bio has recently launched a new software-as-a-service for RNA-Seq and ChIP-Seq analysis, to meet the needs of researchers needing assistance in making decisions based on the large data sets yielded by these types of RNA and epigenetic experiments.
“We are excited to partner with OnRamp.Bio to provide the fastest path to interactive genomic analysis to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Science Exchange is committed to adding the most innovative and qualified service providers to our platform, so scientists have the services they need securely and readily available to aid their discoveries. OnRamp.Bio met our rigorous standards for quality and compliance while demonstrating breakthrough discoveries in the field of genomics.”
About OnRamp BioInformatics, Inc.
OnRamp.Bio is a genomics software company providing bioinformatics analysis software and services, with cost-effective data management platforms for the computing and storage of genomic datasets. To learn more, visit their website www.onramp.bio or follow the company on Twitter @OnRampBio.
February 5, 2018 | Posted by Team in News |
PALO ALTO, Calif., DATE – Science Exchange, the world’s leading enterprise platform for outsourced research and development services and acquisition of human biospecimens, announced today its partnership with Novaseek Research Inc., a health information technology for life sciences company.
Now thousands of researchers using Science Exchange have on-demand access to Novaseek’s Clinical Data Network for Research (CDNR) platform to procure biospecimens, with patient consent and authorization, and associated real-world clinical data in pursuit of accelerating medical innovation. Researchers can utilize the CDNR platform in support of discovery, translational medicine, observational and clinical studies while Science Exchange manages the contracting process and tracks analytics to report performance and process improvement.
“Our CDNR platform can help accelerate the long and costly research process by precisely identifying patient populations with highly specific characteristics, starting early in the development process and continuing throughout,” said Andrei Soran, CEO of Novaseek Research. “Our partnership with Science Exchange enables clinical researchers to focus on getting medicines to market faster while Science Exchange provides operational and service support.”
“The fastest path to novel platforms like Novaseek’s CDNR via Science Exchange helps our leading biopharma clients to accelerate the drug development process and get important medicines to market quickly,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “We are committed to including the best scientific providers on our platform, and Novaseek meets our stringent vetting criteria. By leveraging population analytics, they help streamline study design and free scientists to focus on innovation.”
About Novaseek
Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.
About CDNR
Novaseek’s award-winning, novel, cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time. The CDNR enables researchers to define patient cohorts through population analytics and to access consented biospecimens and clinical data to advance translational medicine, clinical development and observational studies. CDNR enables the fulfillment of complex requests, such as the collection of biospecimens and data before and after specific treatments, without burdening patients with extra blood draws or extensive medical questionnaires. This approach allows more hospitals and patients to participate in supporting biomedical research.
Talk to the Novaseek team today about your biospecimen and clinical data needs — visit their storefront and request a quote with your Scope of Work.
Follow Us